Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Nacuity Pharmaceuticals, a Texas -based clinical stage pharmaceutical company, today announced that they have signed a Technology Proof of Concept (“PoC”) Agreement, with compensation on standard commercial terms.
March 31, 2021
· 5 min read